SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease